팔로우
Amir Ashraf Ganjouei
제목
인용
인용
연도
Mapping 123 million neonatal, infant and child deaths between 2000 and 2017
R Burstein, NJ Henry, ML Collison, LB Marczak, A Sligar, S Watson, ...
Nature 574 (7778), 353-358, 2019
2912019
Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019
GBD 2019 Collaborators, E Nichols, F Abd‐Allah, A Abdoli, AE Abosetugn, ...
Alzheimer's & Dementia: Translational Research & Clinical Interventions 7 (1 …, 2021
1232021
Association between peripheral inflammation and DATSCAN data of the striatal nuclei in different motor subtypes of Parkinson disease
H Sanjari Moghaddam, F Ghazi Sherbaf, M Mojtahed Zadeh, ...
Frontiers in neurology 9, 234, 2018
562018
Longitudinal alterations of alpha-synuclein, amyloid beta, total, and phosphorylated tau in cerebrospinal fluid and correlations between their changes in Parkinson's disease
M Dolatshahi, S Pourmirbabaei, A Kamalian, A Ashraf-Ganjouei, M Yaseri, ...
Frontiers in neurology 9, 560, 2018
492018
Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective
A Javinani, A Ashraf-Ganjouei, S Aslani, A Jamshidi, M Mahmoudi
Immunogenetics 71 (4), 283-297, 2019
412019
Prednisolone as Adjunctive Treatment to Risperidone in Children With Regressive Type of Autism Spectrum Disorder: A Randomized, Placebo-Controlled Trial
M Malek, A Ashraf-Ganjouei, K Moradi, S Bagheri, MR Mohammadi, ...
Clinical Neuropharmacology 43 (2), 39-45, 2020
372020
HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis
M Moghoofei, S Mostafaei, A Ashraf-Ganjouei, H Kavosi, M Mahmoudi
Microbial pathogenesis 114, 436-443, 2018
362018
The association between systemic inflammation and cognitive performance in healthy adults
A Ashraf-Ganjouei, K Moradi, S Bagheri, MH Aarabi
Journal of Neuroimmunology 345, 577272, 2020
312020
White matter tract alterations in drug-naïve Parkinson’s disease patients with impulse control disorders
M Mojtahed Zadeh, A Ashraf-Ganjouei, F Ghazi Sherbaf, M Haghshomar, ...
Frontiers in neurology 9, 163, 2018
312018
Cerebrospinal fluid C-reactive protein in Parkinson’s disease: associations with motor and non-motor symptoms
H Sanjari Moghaddam, Z Valitabar, A Ashraf-Ganjouei, ...
NeuroMolecular Medicine 20 (3), 376-385, 2018
302018
Efficacy and safety of sulforaphane for treatment of mild to moderate depression in patients with history of cardiac interventions: A randomized, double‐blind, placebo …
F Ghazizadeh‐Hashemi, S Bagheri, A Ashraf‐Ganjouei, K Moradi, ...
Psychiatry and Clinical Neurosciences 75 (8), 250-255, 2021
292021
The interplay between gut microbiota and autism spectrum disorders: A focus on immunological pathways
K Moradi, A Ashraf-Ganjouei, H Tavolinejad, S Bagheri, S Akhondzadeh
Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, 110091, 2021
282021
The relationship between cognitive function and body mass index in multiple sclerosis patients
M Owji, A Ashraf-Ganjouei, MA Sahraian, M Bidadian, F Ghadiri, ...
Multiple sclerosis and related disorders 32, 37-40, 2019
262019
IL‐1A rs1800587, IL‐1B rs1143634 and IL‐1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis
S Abtahi, A Farazmand, M Mahmoudi, A Ashraf‐Ganjouei, A Javinani, ...
International journal of immunogenetics 42 (6), 423-427, 2015
262015
Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
A Samaei, K Moradi, S Bagheri, A Ashraf-Ganjouei, R Alikhani, ...
International Journal of Neuropsychopharmacology 23 (12), 775-782, 2020
252020
Melatonin improves learning and memory of mice with chronic social isolation stress via an interaction between microglia polarization and BDNF/TrkB/CREB signaling pathway
S Bagheri, K Moradi, E Ehghaghi, A Badripour, M Keykhaei, ...
European Journal of Pharmacology 908, 174358, 2021
202021
Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial?
A Ayatollahi, S Bagheri, A Ashraf-Ganjouei, K Moradi, MR Mohammadi, ...
Clinical neuropharmacology 43 (5), 139-145, 2020
202020
Serum insulin-like growth factor-1 in Parkinson's disease; study of cerebrospinal fluid biomarkers and white matter microstructure
F Ghazi Sherbaf, B Mohajer, A Ashraf-Ganjouei, M Mojtahed Zadeh, ...
Frontiers in endocrinology 9, 608, 2018
202018
Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease
A Ashraf-Ganjouei, A Majd, A Javinani, MH Aarabi
PeerJ 6, e5539, 2018
202018
Microstructural changes in patients with Parkinson's disease comorbid with REM sleep behaviour disorder and depressive symptoms
F Ghazi Sherbaf, Y Rostam Abadi, M Mojtahed Zadeh, A Ashraf-Ganjouei, ...
Frontiers in neurology 9, 441, 2018
202018
현재 시스템이 작동되지 않습니다. 나중에 다시 시도해 주세요.
학술자료 1–20